These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
64 related articles for article (PubMed ID: 7189692)
1. Quantitative changes in cis-dichlorodiammineplatinum(II) speciation in excreted urine with time after iv infusion in man: methods of analysis, preliminary studies, and clinical results. LeRoy AF; Wehling M; Gormley P; Egorin M; Ostrow S; Bachur N; Wiernik P Cancer Treat Rep; 1980 Jan; 64(1):123-32. PubMed ID: 7189692 [No Abstract] [Full Text] [Related]
2. Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. Patton TF; Himmelstein KJ; Belt R; Bannister SJ; Sternson LA; Repta AJ Cancer Treat Rep; 1978 Sep; 62(9):1359-62. PubMed ID: 688279 [No Abstract] [Full Text] [Related]
3. Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II). Casper ES; Kelsen DP; Alcock NW; Young CW Cancer Treat Rep; 1979; 63(11-12):2023-5. PubMed ID: 575066 [No Abstract] [Full Text] [Related]
4. Cisplatin based chemotherapy in testicular cancer patients: long term platinum excretion and clinical effects. Hohnloser JH; Schierl R; Hasford B; Emmerich B Eur J Med Res; 1996 Sep; 1(11):509-14. PubMed ID: 9438151 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic evidence for an enterohepatic circulation in a patient treated with cis-dichlorodiammineplatinum (II). Vermorken JB; van der Vijgh WJ; Pinedo HM Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):319-28. PubMed ID: 7190316 [TBL] [Abstract][Full Text] [Related]
6. Urine analysis of platinum species derived from cis-dichlorodiammineplatinum(II) by high-performance liquid chromatography following derivatization with sodium diethyldithiocarbamate. Bannister SJ; Sternson LA; Repta AJ J Chromatogr; 1979 May; 173(2):333-42. PubMed ID: 232706 [TBL] [Abstract][Full Text] [Related]
7. Determination of Fe(II) and Zn(II) by spectrophotometry, atomic absorption spectrometry and ions chromatography methods in Vitrum. Zareba S; Szarwiło K; Pomykalski A Farmaco; 2005 May; 60(5):459-64. PubMed ID: 15910818 [TBL] [Abstract][Full Text] [Related]
8. Cobalt speciation study in the cobalt-cysteine system by electrospray ionization mass spectrometry and anion-exchange chromatography inductively coupled plasma atomic emission spectrometry. Bresson C; Colin C; Chartier F; Moulin C Appl Spectrosc; 2005 May; 59(5):696-705. PubMed ID: 15969817 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic study of cis-dichlorodiammineplatinum(II) (DDP) in the beagle dog: thermodynamic and kinetic behavior of DDP in a biologic millieu. LeRoy AF; Lutz RJ; Dedrick RL; Litterst CL; Guarino AM Cancer Treat Rep; 1979 Jan; 63(1):59-71. PubMed ID: 421234 [No Abstract] [Full Text] [Related]
10. Direct determination of cis-dichlorodiammineplatinum(II) in urine by derivative spectroscopy. Inagaki K; Yonehara S; Kidani Y Chem Pharm Bull (Tokyo); 1985 Aug; 33(8):3369-74. PubMed ID: 4085069 [No Abstract] [Full Text] [Related]
11. Improvement of cis-dichlorodiammineplatinum (NSC 119875): therapeutic index in an animal model. Cvitkovic E; Spaulding J; Bethune V; Martin J; Whitmore WF Cancer; 1977 Apr; 39(4):1357-61. PubMed ID: 856436 [TBL] [Abstract][Full Text] [Related]
12. Instability of cis-dichlorodiammineplatinum in dextrose solution. Earhart RH Cancer Treat Rep; 1978 Jul; 62(7):1105-6. PubMed ID: 688249 [No Abstract] [Full Text] [Related]
13. Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Westermann DH; Schefer H; Thalmann GN; Karamitopoulou-Diamantis E; Fey MF; Studer UE J Urol; 2008 Jan; 179(1):163-6. PubMed ID: 18001800 [TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic study of Cis-dichlorodiammine platinum II, in children after rapid infusion. Cano JP; Catalin J; Rigault JP; Bues-Charbit M; Placidi M; Raybaud C; Bernard JL Biomedicine; 1981 Dec; 34(3):146-53. PubMed ID: 7199945 [TBL] [Abstract][Full Text] [Related]
15. A method for determining cis-dichlorodiammineplatinum(II) in plasma and urine by high performance liquid chromatography with direct ultraviolet detection. Kizu R; Higashi S; Miyazaki M Chem Pharm Bull (Tokyo); 1985 Oct; 33(10):4614-7. PubMed ID: 4092275 [No Abstract] [Full Text] [Related]
16. The chemical and immunosuppressive stability of cyclosporine during continuous intravenous infusion. Atkinson K; Britton K; Farrell C; Biggs JC Transplantation; 1983 Nov; 36(5):590-2. PubMed ID: 6227115 [No Abstract] [Full Text] [Related]
18. Some quantitative data on cis-dichlorodiammineplatinum(II) species in solution. LeRoy AF Cancer Treat Rep; 1979 Feb; 63(2):231-3. PubMed ID: 36228 [No Abstract] [Full Text] [Related]
19. Cisplatin containing combination chemotherapy of advanced germ cell line testicular tumours. Bodrogi I; Baki M; Horti J; Géczi L; Liszka G; Ottó S; Hindy I; Eckhardt S; Sugár J Acta Med Hung; 1994; 50(3-4):275-92. PubMed ID: 8587840 [TBL] [Abstract][Full Text] [Related]
20. Intraperitoneal cisplatin and intravenous paclitaxel in the treatment of epithelial ovarian cancer patients with a positive second look. Makhija S; Sabbatini P; Aghajanian C; Venkatraman E; Spriggs DR; Barakat R Gynecol Oncol; 2000 Oct; 79(1):28-32. PubMed ID: 11006026 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]